Blood Research  2013;48(1):67-67

doi:10.5045/br.2013.48.1.67

Many questions raised by a question on JAK1/2 inhibitors in primary myelofibrosis.

Lalit RAUT 1

Affiliations

+expand

Country

Republic of Korea

Language

English

Abstract

No abstract available.